+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bayer AG - logo

Bayer is a global enterprise with a 150 year history in the Life Sciences focused on developing innovative products in the fields of health care and agriculture. Bayer works to meet some of the biggest challenges facing the world today such as the need to promote sustainable agricultural practices to ensure an adequate supply of food and renewable raw materials for the expanding global population as well as working to improve quality of life in an aging society through the prevention and treatment of disease. The Bayer Group is comprised of approx. 302 consolidated companies in 75 countries throughout the world and its headquarters are in Leverkusen, Germany. Bayer became the sole owner of Monsanto Company on June 7 2018.

Feed Palatability Enhancers - Global Strategic Business Report - Product Thumbnail Image

Feed Palatability Enhancers - Global Strategic Business Report

  • Report
  • November 2025
  • 387 Pages
  • Global
From
Sciatica Treatment Market 2025-2029 - Product Thumbnail Image

Sciatica Treatment Market 2025-2029

  • Report
  • August 2025
  • 216 Pages
  • Global
From
Oncology Molecular Diagnostics - Global Strategic Business Report - Product Thumbnail Image

Oncology Molecular Diagnostics - Global Strategic Business Report

  • Report
  • November 2025
  • 158 Pages
  • Global
From
Canola Meal - Global Strategic Business Report - Product Thumbnail Image

Canola Meal - Global Strategic Business Report

  • Report
  • November 2025
  • 193 Pages
  • Global
From
Eczema Therapeutics Market 2024-2028 - Product Thumbnail Image

Eczema Therapeutics Market 2024-2028

  • Report
  • April 2024
  • 172 Pages
  • Global
From
Running Capsules Market - Global Forecast 2025-2032 - Product Thumbnail Image

Running Capsules Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 183 Pages
  • Global
From
From
Angina Pectoris Drugs - Global Strategic Business Report - Product Thumbnail Image

Angina Pectoris Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 196 Pages
  • Global
From
Heart Failure Drugs - Global Strategic Business Report - Product Thumbnail Image

Heart Failure Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 179 Pages
  • Global
From
Pulmonary Edema Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Pulmonary Edema Therapeutics - Global Strategic Business Report

  • Report
  • November 2025
  • 285 Pages
  • Global
From
From
Thrombosis Drugs - Global Strategic Business Report - Product Thumbnail Image

Thrombosis Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 387 Pages
  • Global
From
Atherosclerosis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Atherosclerosis Therapeutics - Global Strategic Business Report

  • Report
  • November 2025
  • 181 Pages
  • Global
From
Fondaparinux - Global Strategic Business Report - Product Thumbnail Image

Fondaparinux - Global Strategic Business Report

  • Report
  • November 2025
  • 180 Pages
  • Global
From
Anti-Hypertensive Drugs - Global Strategic Business Report - Product Thumbnail Image

Anti-Hypertensive Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 293 Pages
  • Global
From
Anti-Platelet Agents - Global Strategic Business Report - Product Thumbnail Image

Anti-Platelet Agents - Global Strategic Business Report

  • Report
  • November 2025
  • 187 Pages
  • Global
From
Loading Indicator